Will Boyer Partner


Speaks:  English

Year of Call: 2013 - Ontario

Primary phone: +1 613-786-0159

Fax: +1 613-788-3423

Email: william.boyer@gowlingwlg.com

Download vCard


Primary office:  Ottawa




Will Boyer

Will Boyer, a "Rising Star" according to Managing Intellectual Property, is an IP litigator and pharmaceutical regulatory law expert. Will's IP litigation expertise is primarily in patent litigation. He also has experience in litigation matters related to trademarks, copyright and trade secrets.

Over the course of his career, Will has worked with a wide variety of clients, from large international companies to small and medium-sized companies. His litigation experience spans many industries, including pharmaceuticals, medical devices, oil-and-gas, computer hardware and software, toys and sports equipment.

Will has appeared as counsel before the Federal Court and the Federal Court of Appeal in patent litigation and judicial review proceedings. Outside of the courtroom, Will advises pharmaceutical clients on issues related to data protection, pricing for patented medicines, listing of patents on Health Canada's Patent Register, and obtaining certificates of supplementary protection. Will is also a registered patent agent. Will credits his success in his legal career to working with a strong team at Gowling WLG.

Prior to joining the firm, Will attended the University of Ottawa, where he completed both his law degree and his bachelor of science in mechanical engineering. He has taken his experience and knowledge back to the University of Ottawa, where he has appeared as a guest lecturer.

Career & Recognition

Filter timeline:
  • 2021

  • 2020

    • Rankings & Awards
       2020
      Managing Intellectual Property (MIP) Rising Star
  • 2019

    • Rankings & Awards
       2019
      Managing Intellectual Property (MIP) Rising Star
  • 2015

    • Career
      October 2015
      Intellectual Property Institute of Canada, Forums & Seminars Committee Member
  • 2014

    • Career
      October 2014
      American Bar Association, International Law Associate
  • 2013

    • Qualifications (Year of Call/Admission, etc.)
       2013
      Year of Call, Ontario
  • 2012

    • Education
       2012
      University of Ottawa, JD, cum laude
  • 2009

    • Education
       2009
      University of Ottawa, BASc, cum laude

Representative Work

  • Bayer Inc et al v Teva / Apotex / Taro / Sandoz / Dr. Reddy / Pharmascience / Accord / Jamp / Mint (T-1960-18 / T-2093-18 / T-435-19 / T-806-19 / T-1187-19 / T-1221-19 / T-270-20 / T-591-20 / T-605-20): Patent litigation under the PM(NOC) Regulations relating to Bayer's blockbuster product XARELTO (rivaroxaban) (counsel for Bayer). These proceedings included precedent setting decisions on inter partes testing in patent litigation (2019 FC 1370; 2020 FCA 71) .
  • Bayer Inc et al v Sandoz (T-1869-21): Patent Litigation under the PM(NOC) Regulations relating to Bayer's ADEMPAS (riociguat) for treatment of pulmonary hypertension (counsel for Bayer).
  • Ideal Products of Canada Ltd v Integrity Products and Supplies Inc et al (T-1730-21): Patent litigation relating to products to protect against corrosion under insulation for industrial piping (counsel for Integrity Products).
  • The Noco Company v Shenzhen Yike Electronics et al (T-484-21): Patent litigation relating to vehicle jump start products (counsel for several defendants).
  • Molo Design, Ltd v Chanel Canada ULC et al (T-379-21): Patent litigation relating to aesthetic elements in Chanel's boutique displays (counsel for Chanel).
  • Cosentino, SAU et al v Cambria Company LLC (T-1422-20): Patent litigation relating to processes for making quartz slabs (counsel for Cosentino).
  • Baker Hughes, a GE Company, LLC et al v Packers Plus Energy Services Inc (T-1494-17): Patent litigation in the oil-and-gas industry relating to downhole tools (counsel for Packers Plus).
  • Seedlings Life Science Ventures LLC v Pfizer Canada Inc (T-608-17): Patent litigation regarding the EpiPen® (counsel for Seedlings).
  • Apotex Inc v Takeda Canada Inc (T-2159-16): Generic section 8 damages relating to nasal sprays containing the corticosteroid ciclesonide (counsel for Takeda).
  • 002152706 Ontario Limited et al v Changer & Dresser Inc et al (T-1202-16; T-1817-16; T-568-17): Patent litigation involving cap changers for welding operations (counsel for Changer & Dresser).
  • Stryker Corporation v Umano Medical Inc (T-191-16): Patent litigation relating to a siderail support for use with a patient support apparatus, eg. a hospital bed (counsel for Stryker). This proceeding included a successful defense of a motion to strike (2016 FC 378).
  • Actton Super-Save Gas Stations Ltd v Broadfence (T-1284-16): Trademark litigation regarding the application of the colour blue to fences (counsel for Broadfence).
  • Louis Garneau Sports Inc c 7898959 Canada Inc faisant affaire sous le nom SS Lacasse (T-965-16): Patent litigation involving cycling seat pads (counsel for SS Lacasse).
  • Walter Surface Technologies Inc v Pearlman Industries Inc et al (T-811-16): Patent litigation involving grinding wheels (counsel for Pearlman).
  • Rapid Completions LLC et al v Baker Hughes Canada Company (T-1569-15): Patent litigation in the oil-and-gas industry relating to a method for using downhole tools to hydraulically fracture a formation (counsel for Rapid Completions and Packers Plus).
  • Horizon Pharma plc v Canada (Health) (T-823-15): Judicial review application relating to data protection for a drug for treating urea cycle disorders (counsel for Horizon). This proceeding included a successful motion for a rare interlocutory stay from the Federal Court (2015 FC 744).
  • Canadian Auto Preservation Inc v The Auto Saver System Inc et al (T-350-15): Patent litigation involving anti-corrosion methods for metal objects, eg. a car (counsel to Auto Saver and LAR).
  • Siemens Product Lifecycle Management Software Inc v John Doe et al (T-937-14): Copyright litigation matter involving computer aided drafting software (counsel for Siemens). This proceeding also led to separate but related proceedings in the Federal Court (T-915-16 and T-20-16).
  • Takeda Canada Inv et al v Mylan Pharmaceuticals ULC (T-1161-13): Patent litigation under the PMNOC Regulations relating to hydrate forms of proton pump inhibitors (counsel for Takeda).
  • Takeda Canada Inv et al v Apotex Inc (T-772-13): Patent litigation under the PMNOC Regulations relating to nasal sprays containing the corticosteroid ciclesonide (counsel for Takeda).
  • ABB Inc et al v Hyundai Heavy Industries Co Ltd (T-735-11, A-379-13): Patent litigation involving gas-insulated switchgear assemblies (counsel for ABB).
  • Gilead Sciences Inc v Idenix Pharmaceuticals Inc (T-1156-12): Patent litigation relating to a revolutionary drug for the treatment of the Hepatitis C virus (counsel for Idenix).
  • Seewind Design Corp v Accenture Business Services For Utilities Inc et al.(Ont. Ct. 11-50541): Trade secret case involving business processes for collection of accounts receivable (counsel for SeeWind).
  • Bayer Inc et al v Cobalt Pharmaceuticals Company et al (T-1044-11): Patent litigation under the PMNOC Regulations relating to oral contraceptive pharmaceutical (counsel for Bayer).